LG and US research institute partner to elucidate the mechanism of cancer and Alzheimer's = South Korean report

According to LG, the company's Artificial Intelligence (AI) Research Institute and the Jackson Laboratory, a non-profit biomedical research institute in the United States, signed a partnership agreement in December last year, and this agreement has now been concluded.
. The two institutions have developed an AI model that analyzes the causes and progression of Alzheimer's disease and cancer, and even predicts the effects of treatment. Conducting treatment research tailored to individual symptoms.
LG's generative AI "EXAONE" is trained to learn the Jackson Laboratory's research materials on the genetic characteristics and life cycle of Alzheimer's disease.
The aim is to analyze the causes and improve the efficiency of treatment. The two institutions will also jointly develop AI that can be used in the field of cancer diagnosis and treatment. Cancer can be detected based on the pathology alone without expensive and special tests.
A multimodal (technology that simultaneously processes multiple information such as images and language) AI model that quickly diagnoses cancer and predicts treatment effects, and anticancer treatment options tailored to the characteristics of individual genetic information.
We will begin the development of a new interactive generative AI that will make suggestions to doctors. Prior to this, in 2022, LG AI Research Institute will use patient genetic information and cancer cell mutation information to kill cancer cells.
We have developed a ``new antigen prediction AI model'' that will guide you. In July of last year, it released ExaOne Discovery, a generative AI platform for developing new drugs, new materials, and new substances.